---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-003398"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:44:34.547550+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical waives default from Biotronik arbitration; amends credit to allow delisting, $3M exposure trigger

## Summary
- Lenders waived Specified Defaults arising from February 16, 2024 arbitration demand by Biotronik/VascoMed.
- Credit agreement amended: delisting no longer a Change in Control; Pending Exposure over $3M becomes Event of Default.
- Lender Warrants amended: removed repurchase option upon delisting; Black-Scholes volatility set to 200%.
- Company paid $100,000 consent fee and must reimburse legal fees of Lenders.
- Company reaffirms all security interests and loan obligations under amended documents.

## SEC filing metadata
- accession: 0000950103-24-003398
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.04, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000095010324003398/0000950103-24-003398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000095010324003398/dp207821_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-003398
- JSON: https://secwatch.observer/filing/0000950103-24-003398.json
- Plain text: https://secwatch.observer/filing/0000950103-24-003398.txt

## Key facts
- Material Agreements
  Acutus Medical, Inc. amended Waiver and Amendment No. 3 to Amended and Restated Credit Agreement and Amendment to Lender Warrants and Warrant Purchase Agreement with Deerfield Partners, L.P. and Deerfield Private Design Fund III, L.P. (effective 2024-03-04).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Deerfield Partners, L.P. and Deerfield Private Design Fund III, L.P.
  - Effective: 2024-03-04
  source text: On March 4, 2024, Acutus Medical, Inc. (the “Company”) and Deerfield Partners, L.P. and Deerfield Private Design Fund III, L.P. (collectively, the “Lenders”) entered into the Waiver and Amendment No. 3 to Amended and Restated Credit Agreement and Amendment to Lender Warrants and Warrant Purchase Agreement (the “Amendment”) to amend (i) the Amended and Restated Credit Agreement, dated as of June 30, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Company, the Lenders from time to time party thereto and Wilmington Trust, National Association, as the Administrative Agent, (ii) warrants to purchase the Company’s common stock (the “Lender Warrants”) issued to each Lender on June 30, 2022 and (iii) the Warrant Purchase Agreement, dated as of June 30, 2022, by and among the Company and the Lenders pursuant to which the Lender Warrants were issued (the “Warrant Purchase Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000095010324003398/0000950103-24-003398-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.